Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Reassuring data on use of blood pressure medications in COVID-19 patients
+News
In print
Reassuring data on use of blood pressure medications in COVID-19 patients
Thursday 4 June 2020, 03:49 PM
HEARTBEAT
Patients might be concerned about what they read and hear in the news regarding the use of renin–angiotensin system blockers during the COVID-19 pandemic. Cardiologist Chris Ellis reviews recent research and current recommendations
Key points, A letter published in March hypothesised that ACE inhibitors and angiotensin II receptor blockers might increase the risk of developing severe and fat
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.